About saypha®
Croma offers a complete range of HA fillers:
- saypha® RICH
- saypha® FILLER
- saypha® VOLUME
- saypha® VOLUME PLUS
The products are based on hyaluronic acid of non-animal origin and are manufactured in accordance with the highest quality standards.
Available with (CE 0123) and without (CE 0459) lidocaine
Range of saypha HA filler
saypha® RICH
The device is a viscoelastic solution to replenish the loss of hyaluronic acid due to ageing, to maintain hydration, improve tone and elasticity of the skin and to act as a filler for small lines such as crow‘s feet, smile lines or smoke lines surrounding the mouth.
saypha® FILLER
For correcting moderate to severe nasolabial folds. Used for cosmetic and medical reconstructive purposes in the treatment of e.g. facial lipoatrophy, debilitating scars or morphological asymmetry
saypha® VOLUME
For correcting moderate to severe nasolabial folds and medical reconstructive treatment, for instance, of facial lipoatrophy, debilitating scars, or morphological asymmetry
saypha® VOLUME PLUS
The intended purpose of the device is to restore facial volume in order to correct moderate to severe midface volume deficit to treat signs of ageing.
Croma syringe
Innovation for safety and comfort
Croma HA fillers
Crosslinked hyaluronic acid with 0.3% lidocaine
saypha® FILLER Lidocaine
Intended purpose
Intended purpose To create volume in order to correct wrinkles and folds in order to treat signs of ageing
Indication
The device is indicated to correct moderate to severe nasolabial folds and to increase lip volume.
Injection area
Phosphate buffer, NaCl, 0.3% lidocaine hydrochloride
Ingredients
Concentration HA
2.3 % (23mg/mL) high molecular weight hyaluronic acid of non-animal origin
Crosslinking agent
BDDE (concentration ≤ 2 ppm)
Additional ingredients
Phosphate buffer, NaCl, 0.3% lidocaine hydrochloride
Packaging
Packaging unit
1 box of 1mL syringe
Needle
2×27G ½” thin wall TerumoTM needles (CE 0197)
Duration
Est. duration in the skin
Anticipated up to 9 months
saypha® VOLUME Lidocaine
Intended purpose
To create volume in order to correct wrinkles and folds in order to treat signs of ageing.
Indication
The device is indicated to correct moderate to severe nasolabial folds.
Injection area
Deep dermis or subcutis
Ingredients
Concentration HA
2.3% (23mg/mL) high molecular weight hyaluronic acid of non-animal origin
Crosslinking agent
BDDE (concentration ≤ 2 ppm)
Additional ingredients
Phosphate buffer, NaCl, 0.3% lidocaine hydrochloride
Packaging
Packaging unit
1 box of 1mL syringe
Needle
2×27G ½” thin wall TerumoTM needles (CE 0197)
Duration
Est. duration in the skin
Anticipated at least 9 months
saypha® VOLUME PLUS
Intended purpose
The intended purpose of the device is to restore facial volume in order to correct moderate to severe midface volume deficit to treat signs of ageing.
Indication
The device is indicated to correct moderate to severe midface volume defi cit in the zygomaticomalar region, anteromedial cheek region and submalar region.
Injection area
Deep subcutaneous and/or supraperiosteal
Ingredients
Concentration HA
2.5% (25mg/mL) high molecular weight hyaluronic acid of non-animal origin
Crosslinking agent
BDDE (concentration ≤ 2 ppm)
Additional ingredients
Phosphate buffer, NaCl, 0.3% lidocaine hydrochloride
Packaging
Packaging unit
1 box of 1mL syringe
Needle
2×27G ½” thin wall TerumoTM needles (CE 0197)
Duration
Est. duration in the skin
Approximately 12 months